These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21878661)
1. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. Saito Y; Tanaka Y; Aita Y; Ishii KA; Ikeda T; Isobe K; Kawakami Y; Shimano H; Hara H; Takekoshi K Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E615-25. PubMed ID: 21878661 [TBL] [Abstract][Full Text] [Related]
2. Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways. Aita Y; Ishii KA; Saito Y; Ikeda T; Kawakami Y; Shimano H; Hara H; Takekoshi K Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1006-14. PubMed ID: 22912364 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells. Ikeda T; Ishii KA; Saito Y; Miura M; Otagiri A; Kawakami Y; Shimano H; Hara H; Takekoshi K J Pharmacol Sci; 2013; 121(1):67-73. PubMed ID: 23269235 [TBL] [Abstract][Full Text] [Related]
4. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889 [TBL] [Abstract][Full Text] [Related]
5. Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways. Lyros O; Mueller A; Heidel F; Schimanski CC; Gockel I; Galle PR; Lang H; Moehler M Int J Cancer; 2010 Sep; 127(5):1197-208. PubMed ID: 20039326 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway. Yeramian A; Sorolla A; Velasco A; Santacana M; Dolcet X; Valls J; Abal L; Moreno S; Egido R; Casanova JM; Puig S; Vilella R; Llombart-Cussac A; Matias-Guiu X; Martí RM Int J Cancer; 2012 Feb; 130(4):967-78. PubMed ID: 21445974 [TBL] [Abstract][Full Text] [Related]
8. Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. Yang F; Jove V; Xin H; Hedvat M; Van Meter TE; Yu H Mol Cancer Res; 2010 Jan; 8(1):35-45. PubMed ID: 20053726 [TBL] [Abstract][Full Text] [Related]
9. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594 [TBL] [Abstract][Full Text] [Related]
10. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells. Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873 [TBL] [Abstract][Full Text] [Related]
11. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation. Cao M; Zhang Z; Han S; Lu X Mol Med Rep; 2019 May; 19(5):3941-3947. PubMed ID: 30864709 [TBL] [Abstract][Full Text] [Related]
12. Puerarin protects differentiated PC12 cells from H₂O₂-induced apoptosis through the PI3K/Akt signalling pathway. Zhang Q; Huang WD; Lv XY; Yang YM Cell Biol Int; 2012 May; 36(5):419-26. PubMed ID: 22126839 [TBL] [Abstract][Full Text] [Related]
13. [Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma]. Cao P; Jiang XJ; Xi ZJ Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):584-589. PubMed ID: 29263493 [TBL] [Abstract][Full Text] [Related]
14. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor. Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853 [TBL] [Abstract][Full Text] [Related]
15. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment. Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015 [TBL] [Abstract][Full Text] [Related]
16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Edelstein J; Hao T; Cao Q; Morales L; Rockwell P Cell Signal; 2011 Jan; 23(1):239-48. PubMed ID: 20851763 [TBL] [Abstract][Full Text] [Related]
18. ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. Yang Y; Ikezoe T; Nishioka C; Taguchi T; Zhu WG; Koeffler HP; Taguchi H Cancer Sci; 2006 Dec; 97(12):1404-9. PubMed ID: 16995874 [TBL] [Abstract][Full Text] [Related]
19. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Chinni SR; Sarkar FH Clin Cancer Res; 2002 Apr; 8(4):1228-36. PubMed ID: 11948137 [TBL] [Abstract][Full Text] [Related]
20. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]